MedPath

Evaluation of Drug Display in Critical Care Setting

Completed
Conditions
Decision Making
Interventions
Device: medication monitor
Registration Number
NCT00715507
Lead Sponsor
University of Utah
Brief Summary

To assess the clinical utility of the graphical medication monitor, results of the anesthetics for which the display was present will be compared to the results of the anesthetics in which there was no display.

Detailed Description

This study has two objectives: First, before the medication monitor is shown to anesthesiologists in a clinical setting, the PKPD models must be validated to assess the clinical reliability of the model-based predictions for patients undergoing general anesthesia. Second, once the PKPD models have been successfully validated, presenting it to anesthesiologists during administration of anesthesia will assess the impact of the graphical medication monitor. Differences in performance and patient care will be determined by comparing anesthesiologists who are presented with the monitor to those who care for patients without the monitor.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Board certified attending anesthesiologists at the University of Utah Health Sciences Center and supervised anesthesiology residents and have been trained on the graphic display
Exclusion Criteria
  • Board certified attending anesthesiologists at the University of Utah Health Sciences Center and supervised anesthesiology residents that have not been trained on the graphic display

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
2medication monitorIn the experimental condition, anesthesiologists will be shown the medication monitor to aid their expertise and decision-making.
Primary Outcome Measures
NameTimeMethod
assess differences between medication administration data and patient information with and without the use of the graphical medication monitor.preoperative, intraoperative and postoperative
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Utah

🇺🇸

Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath